Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice

M Tsuda1, T Suzuki, M Misawa

  • 1Department of Pharmacology, School of Pharmacy, Hoshi University, Tokyo, Japan.

Life Sciences
|January 1, 1997
PubMed

Insights

Nitric oxide synthase (NOS) inhibitors reduced seizure thresholds in mice treated with DMCM and pentylenetetrazole. This suggests endogenous nitric oxide plays a role in seizures induced by GABA(A) receptor inhibitors.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • GABA(A) receptors are crucial inhibitory neurotransmitter receptors in the brain.
  • Nitric oxide (NO) is a signaling molecule implicated in various physiological and pathological processes, including neurological disorders.

Purpose of the Study:

  • To investigate the role of nitric oxide synthase (NOS) in modulating seizure susceptibility.
  • To determine the effect of NOS inhibition on seizure thresholds induced by specific agents.

Main Methods:

  • Mice were administered DMCM (a GABA(A) receptor antagonist) or pentylenetetrazole via intravenous infusion to induce seizures.
  • Mice were pretreated with NOS inhibitors: N-nitro-L-arginine (NOARG) and N-nitro-L-arginine methyl ester (L-NAME).
  • Seizure thresholds were determined by measuring the dose of the convulsant agent required to elicit seizure activity.

Main Results:

  • Pretreatment with NOARG and L-NAME significantly lowered the DMCM-induced seizure threshold.
  • NOS inhibitors also decreased the threshold for pentylenetetrazole-induced seizures.
  • N-nitro-L-arginine did not affect the seizure threshold for caffeine-induced seizures.

Conclusions:

  • Endogenous nitric oxide system activity is important for the expression of seizures induced by GABA(A) receptor inhibitory agents like DMCM and pentylenetetrazole.
  • These findings highlight a potential role for targeting the NO pathway in managing certain types of seizures.

Related Concept Videos